SML3644
JR-AB2-011
≥98% (HPLC)
别名:
3-(3,4-Dichlorophenyl)-1-(4-fluorophenyl)-1-(5-methyl-4,5-dihydrothiazol-2-yl)urea, N-(3,4-Dichlorophenyl)-2-[(4-fluorophenyl)imino]-5-methyl-3-thiazolidinecarboxamide
相关类别
生化/生理作用
JR-AB2-011 is a selective mTORC2 inhibitor that blocks the interaction of Rictor and mTOR (IC50 = 0.31 µM) without affecing mTORC1 activity or assembly. JR-AB2-011 exhibits anti-glioblastoma (GBM) activity in vitro (proliferation IC50 = 0.31 µM post 72h treatment, 36.3% apoptosis post 48h 1 µM treatment in LN229 cultures) and in vivo (4 or 20 mg/kg/d i.p. to LN229 xenografted mice).
Selective mTORC2 inhibitor with anti-GBM efficacy in vitro and in vivo by blocking Rictor and mTOR interaction.
储存分类代码
11 - Combustible Solids
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
历史批次信息供参考:
分析证书(COA)
Lot/Batch Number
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持